WASHINGTON (dpa-AFX) - Teleflex Inc. (TFX), a global provider of medical devices for critical care and surgery, said its ARROW VPS G4 Device has received 510(k) market clearance from the U.S. Food and Drug Administration or FDA. The ARROW VPS G4 Device is used in conjunction with the accompanying disposable ARROW VPS Stylet and would be available in the U.S. in the second quarter 2013.
The ARROW VPS Device is the only system to use micro-Doppler ultrasound technology in combination with intravascular ECG and advanced algorithms to locate the exact location of the lower 1/3 of the superior vena cava and cavo-atrial junction, the ideal location for the tip of a PICC.
The new ARROW VPS G4 Device offers state-of-the-art design and technology, providing easy-to-follow symbols with further enhancements such as statement of final catheter position, improved sterile field capability, and Wi-Fi access to enable integration with hospital data management systems.
Copyright(c) 2013 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
© 2013 AFX News
